BIODESIX INC — Director's Dealing 2021

Apr 7, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2021-04-05

Reporting Person: Georgantas Robert William III (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-05	Common Stock	M	10219	$0.77	Acquired	10774	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-05	Stock Option (Right to buy)	$0.77	M	10219	Disposed	2030-04-14	Common Stock (10219)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	100	Indirect

Footnotes

F1: This option vests 20% on January 1, 2021, and the remaining 80% in 48 successive, equal monthly installments measured from January 1, 2021.

F2: This Form 4 corrects the exercise price previously reported as $0.78 on the Form 3 filed on October 27, 2020.